*	OR T2 T4 T3
R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_temporal Arg1:T2 Arg2:T5	
R3	Has_qualifier Arg1:T8 Arg2:T7	
*	OR T11 T12
*	OR T9 T10
R4	AND Arg1:T8 Arg2:T9	
T1	Measurement 0 19	Response assessment
T2	Value 23 45	complete response (CR)
T3	Value 47 68	partial response (PR)
T4	Value 70 94	long stable disease (SD)
T5	Temporal 95 108	for >3 months
T7	Qualifier 116 122	cancer
T8	Procedure 123 146	immunotherapy treatment
T9	Condition 151 168	metastatic cancer
T10	Condition 172 196	hematologic malignancies
T11	Procedure 214 226	marketed CPI
T12	Observation 238 291	participation in a Roche/Genentech CPI clinical trial
T14	Non-representable 294 381	Availability of tumor biopsy material extracted and preserved by the investigating site
